by Raynovich Rod | Feb 3, 2016 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
2/5/16 …11:20 AM Biotechs Can’t Hold Gains …Drop Back Near 52 Week Lows Hit Wednesday IBB $261 XBI $48 Update-2 At Close 2/4/16…Nice Rally But Off Earlier Highs-Very Stock Specific A nice snap-back rally with a lot of green screen across the...
by Raynovich Rod | Feb 2, 2016 | 2025 Rayno Biopharmaceuticals Portfolio
Where is the Growth Potential in Large Cap Biopharmaceutical Companies? Caution: Risk Aversion Remains High Investing in biotech stocks ain’t getting easier. The sector is underperforming the market by 16% YTD, sentiment has been burned by concerns about drug...
by Raynovich Rod | Jan 20, 2016 | 2025 Rayno Biopharmaceuticals Portfolio
Can the Reversal Hold? IBB Rockets up 2.75% to 285.49 after hitting 52 week low today at 268.52. XBI up 4.22% to $55.09. Notable movers: Large caps: ABBV, ALXN, AMGN, REGN; BIIB down 0.19%, GILD lagging up only 0.72%. Mid-caps all green: ALKS,CLVS,SGEN,VRTX. All Rayno...
by Raynovich Rod | Jan 18, 2016 | 2025 Rayno Biopharmaceuticals Portfolio
Valuation Models for Large Cap Biopharma Stocks Can Robust Drug Pipelines Deliver Future EPS Growth? This is a follow-up of our post on 1/8/16 Large Cap Biopharmaceuticals which looks at valuation models and stock performance of selected companies after the...
by Raynovich Rod | Jan 8, 2016 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Large Cap Biopharmaceutical Stock Valuations After Correction We previously summarized the Rayno Mid and Small Cap Portfolios for 2015, a good year despite the correction. With this post we summarized selected Sales and Earnings metrics (Source finviz.com) of...
by Raynovich Rod | Jan 3, 2016 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Biotech Winners 2015: Rayno Mid-Cap Performance Rayno Biopharmaceutical Portfolios beat the bellwether IBB in 2015 . We previously reviewed the Rayno Small Cap Portfolio which was up 38.1% in Q4 2015 and the Mid-Caps also beat despite a big loss by Clovis Oncology...
by Raynovich Rod | Dec 29, 2015 | 2025 Rayno Biopharmaceuticals Portfolio
Rayno Small Cap Biopharmaceuticals -Strong Rally, Good Momentum with Overall Market We recommended three new small caps at the October Bioinvestor Forum: Curis (CRIS) Geron (GERN) and Ocera Therapeutics. This BIO sponsored forum offers the best window on emerging...
by Raynovich Rod | Dec 28, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Biopharma Rally On Hold When you read the Transfs online trading guide, you will begin to understand that trading can be a volatile investment. There will be amazing days, weeks, or months where rates are perfect for you but there will also be days, weeks, or months...
by Raynovich Rod | Dec 16, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Update after close 12/16…IBB up 2.25%, XBI up 4.45% Rayno Life Science Big Movers Rayno Biopharma ABBV up 2.2%,ALKS up 8.12%, BIIB up 3.52%, ARRY up 20.63 %, CRIS up 6.27%, FCSC up 5%, GERN up 4.42%,RXDX up 2.92% and SGEN up 4.93%. Rayno Dx and Tools ABAX up...
by Raynovich Rod | Dec 1, 2015 | 2025 Rayno Biopharmaceuticals Portfolio, Biopharmaceuticals
Look for Growth in Emerging Small Cap Drug Stocks Many stocks were in the red Monday with healthcare a lagging sector down 1%. Many investors await economic data later this week and the mid-December meeting for the FED. Biotech stocks are also weak today with the...
